Breyna 160-4.5 MCG inhaler 10.3GM
Ended Awarded Last action
- Contract number
- SPE2DR26F4F0A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,661
Award facts
- Contract value 100% obligated
- $29,661.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,661.37 to AmerisourceBergen Drug Corp for the supply of Breyna 160-4.5 microgram inhaler in 10.3-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026, and was awarded on January 13, 2026. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products across multiple therapeutic domains, with all reviewed awards being competitively awarded on a full and open basis. Through its parent company's significant IDC with the DLA, AmerisourceBergen maintains the capability to supply specialty medications, brand-name and generic drugs, vaccines, and other essential medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F4F0A?
SPE2DR26F4F0A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F4F0A worth?
The government has obligated $29,661 on SPE2DR26F4F0A.
Is contract SPE2DR26F4F0A an order under another contract?
Yes. SPE2DR26F4F0A is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F0A competed?
The extent of competition for SPE2DR26F4F0A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award